The Trump administration on Thursday moved FDA-approved marijuana products and cannabis products sold under qualifying state medical marijuana licenses from Schedule I to Schedule III under federal law, while also setting a new June 29, 2026 administrative hearing to restart and expedite the broader DEA rescheduling process. The Justice Department said the immediate action is […]